<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="33353">Technetium</z:chebi>-99m ethyl <z:chebi fb="0" ids="32457">cysteinate</z:chebi> dimer (Tc-99m <z:mp ids='MP_0010412'>ECD</z:mp>) brain single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography (SPECT) was used to detect abnormal regional cerebral blood flow (rCBF) in primary <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (PAPS) patients </plain></SENT>
<SENT sid="1" pm="."><plain>The patients had mild neuropsychiatric manifestations and <z:mpath ids='MPATH_458'>normal</z:mpath> brain magnetic resonance imaging (MRI) findings in this preliminary study </plain></SENT>
<SENT sid="2" pm="."><plain>Fifteen such female PAPS patients were examined with Tc-99m <z:mp ids='MP_0010412'>ECD</z:mp> brain SPECT in order to evaluate the rCBF </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, serum anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies (ACA) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) were simultaneously measured for comparison </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: (a) Tc-99m <z:mp ids='MP_0010412'>ECD</z:mp> brain SPECT revealed hypoperfusion <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">brain lesions</z:e> in 12 (80%) of the PAPS patients </plain></SENT>
<SENT sid="5" pm="."><plain>Pariental lobes were the most commonly involved areas </plain></SENT>
<SENT sid="6" pm="."><plain>(b) 11 (73%) and 9 (60%) cases had positive ACA and positive LA, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, ACA and LA results were correlated to the Tc-99m <z:mp ids='MP_0010412'>ECD</z:mp> brain SPECT findings </plain></SENT>
<SENT sid="8" pm="."><plain>Tc-99m <z:mp ids='MP_0010412'>ECD</z:mp> brain SPECT is a sensitive tool for detecting abnormal rCBF in PAPS patients with mild neuropsychiatric manifestations and <z:mpath ids='MPATH_458'>normal</z:mpath> brain MRI findings </plain></SENT>
</text></document>